Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$153,641,470
+$66,003,631 QoQ
Shares Held
4,341,381
+37.2% QoQ
Ownership
0.601%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#29
of 494 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Sep 30, 2023CallValue
$2,810,208
CallShares
240,600
PutValue
$2,803,200
PutShares
240,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ROIV ranks #15 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ROIV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $153,641,470 | 4,341,381 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $87,637,839 | 3,163,821 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $63,544,715 | 2,928,328 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $40,666,485 | 2,687,805 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $29,888,521 | 2,652,043 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,410,956 | 2,320,214 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $20,327,119 | 1,718,269 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $24,622,109 | 2,133,632 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $27,944,085 | 2,643,717 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,716,863 | 2,250,177 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,550,205 | 761,372 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,810,208 | 240,600 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $13,021,947 | 1,114,893 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $2,803,200 | 240,000 | Put | Defined | 2023-11-14 | |
| 2023-06-30 | $10,361,068 | 1,027,884 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,595,176 | 1,029,157 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,707,574 | 213,714 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $104,073 | 32,321 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $83,756 | 20,579 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $398,745 | 80,718 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||